Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 05, 2019

SELL
$35.43 - $56.29 $1.47 Million - $2.34 Million
-41,603 Closed
0 $0
Q3 2018

Nov 09, 2018

BUY
$44.22 - $75.47 $28,123 - $47,998
636 Added 1.55%
41,603 $2.37 Million
Q2 2018

Aug 10, 2018

SELL
$72.38 - $92.5 $64,345 - $82,232
-889 Reduced 2.12%
40,967 $3.27 Million
Q1 2018

May 08, 2018

SELL
$69.46 - $88.57 $199,280 - $254,107
-2,869 Reduced 6.41%
41,856 $3.63 Million
Q4 2017

Feb 08, 2018

SELL
$65.94 - $93.31 $147,309 - $208,454
-2,234 Reduced 4.76%
44,725 $3.09 Million
Q3 2017

Nov 08, 2017

SELL
$80.87 - $91.08 $502,687 - $566,153
-6,216 Reduced 11.69%
46,959 $4.27 Million
Q2 2017

Aug 10, 2017

BUY
N/A
53,175
53,175 $3.96 Million

Others Institutions Holding NVRO

About NEVRO CORP


  • Ticker NVRO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,387,800
  • Market Cap $305M
  • Description
  • Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...
More about NVRO
Track This Portfolio

Track Roosevelt Investment Group LLC Portfolio

Follow Roosevelt Investment Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Roosevelt Investment Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Roosevelt Investment Group LLC with notifications on news.